serine and lrrk2-in1

serine has been researched along with lrrk2-in1 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alessi, DR; Davies, P; Deng, X; Dzamko, N; Gray, NS; Lee, JD; Liu, Q; Nomanbhoy, TK; Patricelli, MP; Prescott, A; Yang, Q1
Bolognesi, P; Frassineti, M; Longo, F; Mercatelli, D; Morari, M; PisanĂ², CA; Shimshek, DR1

Other Studies

2 other study(ies) available for serine and lrrk2-in1

ArticleYear
Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2.
    Nature chemical biology, 2011, Volume: 7, Issue:4

    Topics: Benzodiazepinones; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; HEK293 Cells; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Mutation; Parkinson Disease; Phosphorylation; Protein Serine-Threonine Kinases; Pyrimidines; Serine

2011
Leucine-rich repeat kinase 2 (LRRK2) inhibitors differentially modulate glutamate release and Serine935 LRRK2 phosphorylation in striatal and cerebrocortical synaptosomes.
    Pharmacology research & perspectives, 2019, Volume: 7, Issue:3

    Topics: Aminopyridines; Animals; Benzamides; Benzodiazepinones; Corpus Striatum; Dopamine; Exocytosis; Gene Knock-In Techniques; Glutamic Acid; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Mice; Phosphorylation; Pyrimidines; Serine; Synaptosomes; Visual Cortex

2019